Mylan CEO to Defend EpiPen Price Increase Before Congress

Mylan CEO to Defend EpiPen Price Increase Before Congress-abcnews: Mylan Pharmaceuticals CEO Heather Bresch is expected to defend her company’s increase in EpiPen pricing when she testifies before Congress tomorrow by maintaining that the company simultaneously expanded access to the emergency allergy medication, according to an advanced copy of her remarks obtained by ABC News.